JEQUETTA MCLAURIN: Open Payments
NPI 1013698513 · JACKSON, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$431 in 17 payments from 6 companies in 2025. Trend: 2023 $17 · 2024 $288 · 2025 $431
Food & beverage: $431
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 8 | $142 |
| AstraZeneca Pharmaceuticals LP | 1 | $122 |
| ABBVIE INC. | 3 | $53 |
| PFIZER INC. | 2 | $49 |
| Axsome Therapeutics, Inc. | 2 | $43 |
| Gilead Sciences, Inc. | 1 | $24 |
Products named: BREZTRI, Ozempic, VRAYLAR, PREVNAR 20, Auvelity, Epclusa, Rybelsus.
Industry payments across MS — which companies pay providers there.
